Characterization of patients with COVID-19 in Guamá municipality
Abstract
Introduction: COVID-19 patients were reported in Santiago de Cuba in March 2020; however, transmission began in the Guama municipality in December of that year, with 2,449 confirmed cases and 20 deaths by the end of the third wave.
Objective: To characterize the epidemic of Covid-19 in Guamá municipality from December, 2020 to October, 2021.
Methods: A cross-sectional descriptive study was carried out, to characterize the epidemic of Covid-19 in Guamá municipality from December, 2020 to October, 2021 according to demographic, clinical and epidemiologic variables of interest, including mortality from this cause.
Results: There was a prevalence of the 45-54 age group and the female sex; the most frequent symptoms were fever (59.4 %) and cough (53.5 %); 28.2 % of patients presented hypertension.
Conclusions: The COVID-19 was associated with a high morbidity and mortality in patients over 55 years with chronic diseases. There was a prevalence of the autochthonous source of infection and the symptomatic clinical form; corresponding to an upper respiratory infection. The mortality and lethality were similar to those in the province and the country.
Downloads
References
1. Cuba por la vida .La Habana: Ministerio de Salud Pública; © 2025[actualizada 2020 mar 30; citado 2025 jul 23]. Nota informativa sobre Nuevo coronavirus: primeros casos confirmados en Cuba; [aprox. 1 p.]. Disponible en: https://salud.msp.gob.cu/?p=4272&doing_wp_cron=1754414767.9112639427185058593750
2. Cuba por la vida.La Habana: Ministerio de Salud Pública; © 2025[actualizada 2023 abr 21 ; citado 2025 jul 23]. Parte de cierre del día 20 de abril a las 12 de la noche
; [aprox. 1 p.] . Disponible en: https://salud.msp.gob.cu/?p=33805
3.Chen G, Wu D, Guo W, Cao Y, Juang D, Wang H, et al. Clinical and immunology features in severe and moderate coronavirus disease 2019. J Clin Invest. 2020[citado 20/08/2022];130 (5):2620-29. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7190990/pdf/jci-130-137244.pdf
4. Salinas Aguirre JE, Sánchez García C, Rodríguez Sánchez R, Rodríguez Muñoz L, Díaz Castaño A, Bernal Gómez R. Características clínicas y comorbilidades asociadas a mortalidad en pacientes con COVID-19 en Coahuila (México) [Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico)]. Rev Clin Esp. 2022[citado 20/08/2024];222(5), 288–92. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7816557/
5. Yang J, Zhng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comomorbidities in the novel Wuhan coronavirus COVID-19 (Infection a systematic review and meta-analysis. International Journal Infection Disease. 2020[citado 08/08/2022];94: 91-5. Disponible en:
https://doi.org/10.7363/090125.
6. Schurz H, Salie M, Tromp G, Hoal E, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Human genomics. 2019[citado 20/08/2022];13(1):2. Disponible en: https://humgenomics.biomedcentral.com/articles/10.1186/s40246-018-0185-z
7.- Klein SL, Flanagan KL. Sex differences in immune responses. Nature Reviews Inmunology .2016[citado 16/08/2022];16:626-38. Disponible en: https://doi.org/10.1038/nri2016.
8. Aja Díaz A, Molina Cintra MC, Trinquete Díaz DE, Barros Díaz OZ, Rodríguez García A, Orbea López M, et al. Demografía y COVID-19: Diferenciales sociales y epidemiológicos. Anales de la Academia de Ciencias de Cuba. 2022[citado 24/06/2024]; 12(3). Disponible en: http://scielo.sld.cu/pdf/aacc/v12n3/2304-0106-aacc-12-03-e1115.pdf
9.- Cuello Carballo MB, Díaz Alfonso H, Cruz Quesada JE, Carbó Rodríguez HL, Dopico-Ravelo D. Caracterización clínico-epidemiológica de los pacientes confirmados con la COVID-19 en Pinar del Río. Rev Ciencias Médicas. 2020 [citado 08/03/2022]; 24(5): e4581. Disponible en: http://scielo.sld.cu/pdf/rpr/v24n5/1561-3194-rpr-24-05-e4581.pdf
10. Jiménez Franco L, Gutiérrez Pérez D, Montenegro Calderón T. Caracterización clínico-epidemiológica de los casos positivos de COVID-19 en Cienfuegos en el mes de marzo de 2021. 2021[citado08/03/2022];60(280): Disponible en: http://www.rev16deabril.sld.cu/index.php/16_04/article/view/1206
11.Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases onboardthe Diamond Princess cruiseship, Yokohama, Japan. 2020[citado 25/04/2022]; 25(10). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078829
12.- Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Perú Med Exp Salud Pública. 2020 [citado 25/04/2022];37(2). Disponible en : http://www.scielo.org.pe/pdf/rins/v37n2/1726-4642-rins-37-02-253.pdf
13.-Peña García Y, Suárez Padilla A, Arruebarrena Blanco NM. Caracterización de casos positivos y sospechosos de COVID-19 con co-morbilidades. Rev. Finlay. 2020[citado 08/03/2022];10(3):314-9. Disponible en: http://scielo.sld.cu/pdf/rf/v10n3/2221-2434-rf-10-03-314.pdf
14. Cuba por la vida [Internet].La Habana: Ministerio de Salud Pública; © 2025[actualizada 2021 abr 19; citado 2025 jul 23]. Cuba mantiene las medidas de control sanitario en viajeros internacionales; [aprox. 1 p.] . Disponible en: https://salud.msp.gob.cu/?p=9705
15.- Ferrer Castro J, Sánchez Hernández E, Poulout Mendoza A. Caracterización clínica y epidemiológica de pacientes confirmados con la COVID-19 en la provincia de Santiago de Cuba. Medisan. 2020[citado 24/05/2022];24(3):473. Disponible en: http://medisan.sld.cu/index.php/san/article/view/3145
16.- González Lara D, Sánchez Hernández E, Labrada Chacón L, Ferrer Castro JE, Moreno Reyes JC. Características clínico-epidemiológicas de pacientes sospechosos y confirmados con la COVID-19 en una comunidad con régimen de cuarentena. MEDISAN. 2022 [citado 29/05/2022] Disponible en: http://medisan.sld.cu/index.php/san/article/view/4045/html.
17.Díaz Lazo A, Montalvo Otivo R, Lazarte Nuñez E, Aquino López E. Caracterización clínica y epidemiológica de los pacientes con COVID-19 en un hospital situado en la altura. Horiz. Med. 2021[citado04/03/2022]; 21(2): e1303. Disponible en: http://www.scielo.org.pe/pdf/hm/v21n2/1727-558X-hm-21-02-e1303.pdf
18. Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Seccional, Multicenter Study. The American journal of gastroenterology. 2020[citado 28/03/2022]; 115(5), 766–3. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7172492/pdf/acg-publish_ahead_of_print-10.14309_ajg.0000000000000620.pdf
19. Diaz Morales Y, Tejeda Castañeda E, Díaz Padrón EG, Santiago Lopez W, Oyarzabal GA, Calderón Medina NA. Caracterización clínica y epidemiológica de pacientes con la COVID-19. Rev Cub Med Mil. 2021[citado24/06/2024];50(1). Disponible en: http://scielo.sld.cu/pdf/mil/v50n1/1561-3046-mil-50-01-e815.pdf
20. Hierrezuelo Rojas N, González Fernández P, Leon Gilart A, Cordero Castillo F. Caracterización clínico-epidemiológica de pacientes con la COVID-19 en el policlínico Ramón López Peña. Rev. cuba. hig. epidemiol. 2021 [citado 25/06/2024];58. Disponible en: https://revepidemiologia.sld.cu/index.php/hie/article/view/1117
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 MEDISAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
